News about Research
- Jan (21)
- Feb (19)
- Mar (23)
- Apr (22)
- May (22)
- Jun (20)
- Jul (27)
- Aug (10)
- Sep (24)
- Oct (24)
- Nov (34)
- Dec (20)
- Jan (24)
- Feb (27)
- Mar (15)
- Apr (23)
- May (34)
- Jun (28)
- Jul (26)
- Aug (11)
- Sep (19)
- Oct (20)
- Nov (28)
- Dec (14)
- Jan (14)
- Feb (22)
- Mar (21)
- Apr (12)
- May (20)
- Jun (23)
- Jul (20)
- Aug (5)
- Sep (19)
- Oct (19)
- Nov (26)
- Dec (15)
- Jan (4)
- Feb (18)
- Mar (13)
- Apr (15)
- May (19)
- Jun (22)
- Jul (18)
- Aug (9)
- Sep (11)
- Oct (25)
- Nov (19)
- Dec (15)
- Jan (12)
- Feb (6)
- Mar (13)
- Apr (5)
- May (7)
- Jun (15)
- Jul (11)
- Aug (3)
- Sep (5)
- Oct (8)
- Nov (15)
- Dec (13)
Eight IDIBAPS researchers participate in the seventh edition of the #científiques project
On February 11, the scientists will visit different schools throughout Catalonia to explain their research to students between 11 and 13 years old, o1
An app helps to control Type 2 diabetes by promoting a healthy lifestyle
A team of researchers at IDIBAPS-Hospital Clínic Barcelona has shown that the Greenhabit mobile application can be useful for controlling Type 2 diab1
Genetic studies help us classify and better understand testicular B-cell lymphoma
A team from Clínic-IDIBAPS led a collaborative study that characterized in detail the genetic profile of testicular B-cell lymphoma, a very rare lymp1
An international project involving IIBB-CSIC-IDIBAPS aims to study the relationship between hypercaloric diets and liver cancer
The National Cancer Institute of the National Institutes of Health (NIH) will fund a project that aims to decipher the molecular mechanisms by which1
The Knowledge and Technology Transfer Office has a new page on the IDIBAPS website
An international study led by a researcher from IDIBAPS-Hospital Clínic Barcelona demonstrates the first significant improvement in the treatment of a subtype of liver cancer in twenty years
The journal The Lancet has published the results of a phase III clinical trial led by Josep Maria Llovet, from IDIBAPS-Hospital Clínic Barcelona. Inv1
Advances made in CAR-T immunotherapy to prevent relapse in multiple myeloma
A team from Clínic-IDIBAPS has introduced a modification to a CAR-T immunotherapy for multiple myeloma that makes it more durable, according to resul1
A European project led by IDIBAPS-Hospital Clínic Barcelona studies the efficacy of immunotherapy for childhood melanoma for the first time
Conducted as part of the MELCAYA project, the study demonstrates that anti PD-1 antibody immunotherapy is safe for children and adolescents. Furtherm1
IDIBAPS launches its eighth photography competition
Workers from IDIBAPS and other Campus Clínic organisations are eligible to take part. Each worker may submit a maximum of 3 photographs.